Multiple indications for anti-inflammatory apolipoprotein mimetic peptides

Brian J Van Lenten1, Mohamad Navab, G M Anantharamaiah

  • 1David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA. bvanlent@mednet.ucla.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|October 28, 2008
PubMed
Summary

Apolipoprotein mimetic peptides show promise for treating atherosclerosis and other inflammatory diseases. These peptides effectively reduce vascular inflammation in animal models, suggesting broad therapeutic potential.